AI assistant
Sending…
Armata Pharmaceuticals, Inc. — Director's Dealing 2019
May 20, 2019
34152_dirs_2019-05-20_ab1a79ac-0121-4696-9594-756035a722f8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Armata Pharmaceuticals, Inc. (ARMP)
CIK: 0000921114
Period of Report: 2019-05-09
Reporting Person: Delta Dental of Wisconsin, Inc. (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1628994 | Direct |
| Common Stock | 478681 | Indirect |
Footnotes
F1: Held by Wyssta Investments, Inc., which is a wholly-owned subsidiary of Delta Dental of Wisconsin. Delta Dental of Wisconsin is an indirect beneficial owner of the reported securities.
More from Armata Pharmaceuticals, Inc.
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 27
Regulatory Filings
2026
Apr 27
Annual Report
2026
Mar 25
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Feb 23